Gary M. Karp

2.5k total citations
21 papers, 281 citations indexed

About

Gary M. Karp is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Gary M. Karp has authored 21 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Gary M. Karp's work include Hepatitis C virus research (4 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Fluorine in Organic Chemistry (3 papers). Gary M. Karp is often cited by papers focused on Hepatitis C virus research (4 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Fluorine in Organic Chemistry (3 papers). Gary M. Karp collaborates with scholars based in United States and Switzerland. Gary M. Karp's co-authors include James A. Marcum, R D Rosenberg, SJ Galli, Linda M.S. Fritze, Marla Weetall, Xin Zhao, Zhihua Feng, Chien‐Ping Ko, Chunyi Zhou and Nikolai A. Naryshkin and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Gary M. Karp

21 papers receiving 255 citations

Peers

Gary M. Karp

GENET

HEPAT

HEMAT

Kenneth J. Wiggall United States

Richard D. Caldwell United States

Lisa Hettrick United States

P Steinmetzer Germany

Jean-Pierre Evenou Switzerland

Agustin Casimiro‐Garcia United States

Weiqiong Zuo China

Stefan Buck Germany

Jörg Hauptmann Germany

Randall W. Steinkampf United States

Kenneth J. Wiggall United States

Gary M. Karp

199 ×1.7

104 ×0.9

18 ×0.3

GENET

34 ×1.2

HEPAT

65 ×2.4

HEMAT

Citations per year, relative to Gary M. Karp Gary M. Karp (= 1×) peers Kenneth J. Wiggall

Countries citing papers authored by Gary M. Karp

Since Specialization

Citations

This map shows the geographic impact of Gary M. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Karp more than expected).

Fields of papers citing papers by Gary M. Karp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary M. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Karp. The network helps show where Gary M. Karp may publish in the future.

Co-authorship network of co-authors of Gary M. Karp

This figure shows the co-authorship network connecting the top 25 collaborators of Gary M. Karp. A scholar is included among the top collaborators of Gary M. Karp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary M. Karp. Gary M. Karp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Narasimhan, Jana, Aleksey I. Gerasyuto, Jiashi Wang, et al.. (2022). Ribonucleotide reductase, a novel drug target for gonorrhea. DSpace@MIT (Massachusetts Institute of Technology). 8 indexed citations

Gerasyuto, Aleksey I., Michael Arnold, Jiashi Wang, et al.. (2018). Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria. Journal of Medicinal Chemistry. 61(10). 4456–4475. 9 indexed citations

Graci, Jason D., Guangming Chen, Gillian M. Schiralli Lester, et al.. (2017). Identification of benzazole compounds that induce HIV-1 transcription. PLoS ONE. 12(6). e0179100–e0179100. 2 indexed citations

Arnold, Michael, Aleksey I. Gerasyuto, Jiashi Wang, et al.. (2017). 4-Hydroxy-2-pyridones: Discovery and evaluation of a novel class of antibacterial agents targeting DNA synthesis. Bioorganic & Medicinal Chemistry Letters. 27(22). 5014–5021. 9 indexed citations

Feng, Zhihua, Karen Ling, Xin Zhao, et al.. (2016). Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Human Molecular Genetics. 25(5). 964–975. 48 indexed citations

Zhang, Nanjing, Anthony Turpoff, Xiaoyan Zhang, et al.. (2015). Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B. Bioorganic & Medicinal Chemistry Letters. 26(2). 594–601. 10 indexed citations

Chen, Guangming, Hongyu Ren, Nanjing Zhang, et al.. (2015). 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B. Bioorganic & Medicinal Chemistry Letters. 25(4). 781–786. 10 indexed citations

Naryshkin, Nikolai A., Amal Dakka, Vijayalakshmi Gabbeta, et al.. (2015). Small molecule compounds that promote exon skipping in the DMD gene. Neuromuscular Disorders. 25. S261–S261. 1 indexed citations

Chen, Guangming, Hongyu Ren, Anthony Turpoff, et al.. (2013). Discovery of N-(4′-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication. Bioorganic & Medicinal Chemistry Letters. 23(13). 3942–3946. 15 indexed citations

10.

Gu, Zhengxian, Jason D. Graci, Frederick Lahser, et al.. (2013). Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein. Antimicrobial Agents and Chemotherapy. 57(7). 3250–3261. 15 indexed citations

11.

Karp, Gary M., et al.. (2000). Preparation of 4-Hydroxy-2-trifluoromethylthiophene: A Novel Bioisostere of α,α,α-Trifluoro-m-cresol. Synthesis. 2000(8). 1078–1080. 4 indexed citations

12.

Karp, Gary M.. (1999). An Expeditious Route to Novel 1,4,2-Benzodiazaphosphepin-5-one 2-Oxide Analogues. The Journal of Organic Chemistry. 64(22). 8156–8160. 18 indexed citations

13.

Karp, Gary M., et al.. (1997). Synthesis and Herbicidal Activity of 1H-1,4-Benzodiazepine-2,5-diones. Journal of Agricultural and Food Chemistry. 45(2). 493–500. 16 indexed citations

14.

Karp, Gary M.. (1996). Synthesis and alkylation of 3,4‐dihydro‐1H‐1,3‐4‐benzotriazepine‐2,5‐diones and related systems. Journal of Heterocyclic Chemistry. 33(4). 1131–1135. 2 indexed citations

15.

Singh, Bijay, et al.. (1996). Benzodiazepinediones: A New Class of Photosystem-II-Inhibiting Herbicides. Pesticide Biochemistry and Physiology. 56(1). 62–68. 3 indexed citations

16.

Karp, Gary M., et al.. (1994). Preparation and alkylation of regioisomeric tetrahydrophthalimide‐substituted indolin‐2(3H)‐ones. Journal of Heterocyclic Chemistry. 31(6). 1513–1520. 6 indexed citations

17.

Karp, Gary M.. (1993). PREPARATION AND REACTIONS OF INDOLIN-2(3H)-ONES. A REVIEW. Organic Preparations and Procedures International. 25(5). 481–513. 17 indexed citations

18.

Karp, Gary M.. (1992). Regioselective alkylation of phenoxy-substituted 3-(methylthio)indolin-2(3H)-ones. Preparation of 3-, 1,3-, and 1,3,3-substituted indolin-2(3H)-ones. The Journal of Organic Chemistry. 57(17). 4765–4772. 10 indexed citations

19.

Marcum, James A., Linda M.S. Fritze, SJ Galli, Gary M. Karp, & R D Rosenberg. (1983). Microvascular heparin-like species with anticoagulant activity. American Journal of Physiology-Heart and Circulatory Physiology. 245(5). H725–H733. 54 indexed citations

20.

Karp, Gary M., et al.. (1982). Preparation and reactions of [2,2-bis(carbethoxy)propyl]cyclopentadienyldicarbonyliron. Journal of Organometallic Chemistry. 236(2). 257–266. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact